Expert advice for every grant — from EPA to DARPA

The Complement-ARIE program funds seven technology centers to develop human-based models that complement animal research. What it means for drug developers, academic researchers, and the regulatory pipeline.

The NSF Tech Labs initiative will fund independent research organizations with $10-50M annually on milestone-based contracts. A deep analysis of the biggest structural shift in NSF funding in decades.

The TechAccess: AI-Ready America initiative will fund up to 56 coordination hubs at $1M/year each, with USDA, DOL, and SBA as co-sponsors. First applications due July 16.

The reclassification of 50,000 federal employees under Schedule Policy/Career threatens to politicize the grant-making officials who decide which science gets funded. A deep analysis of what is at stake.

HHS launched the STREETS Initiative and SAMHSA announced $69M in mental health grants as part of the Great American Recovery. A deep analysis of eligibility, strategy, and what organizations should apply.

NIH has quietly stopped issuing agency-directed funding announcements, with 271 fully developed NOFOs stuck in political review. What the shift to unsolicited science means for researchers.

The USDA Regenerative Pilot Program offers $700M through EQIP and CSP with a single application process. A deep analysis of eligibility, practices, and strategy for farmers at every level.

The Spencer Foundation launched a dedicated AI and Education initiative funding research through multiple grant programs. Here is the full landscape of who is paying for answers about AI in schools.

ARPA-H PROSPR program funds seven research teams testing rapamycin, semaglutide, and novel compounds to extend healthspan. A deep analysis of the science, the money, and what it means for the field.

The FY2026 spending bill rejected 40% NIH cuts and preserved education grants. A line-by-line analysis of what passed, what the numbers mean for grant seekers, and where the money is going.

Legal Services Corporation survived an elimination attempt, secured $540M in bipartisan funding, and is now opening competitive 2027 field grants. What legal aid organizations need to know.

A new PNAS study finds women lost 57.9% of their NIH grant funding versus 48.2% for men. A companion STAT survey of 1,000 researchers reveals mass layoffs and canceled research.

NIH paylines vary by institute, career stage, and fiscal year. Learn how percentile cutoffs, select pay, and budget dynamics determine whether your R01 gets funded.

NIH reviewers score innovation differently than most applicants expect. A detailed look at what study sections reward, what they penalize, and how the criterion has evolved.

With R01 success rates at 13% and paylines tightening, the Significance section is where most proposals win or die. How to write the one that survives.

A paragraph-by-paragraph breakdown of the NIH R01 Specific Aims page, with structural guidance, reviewer psychology, and the mistakes that sink fundable science.

How to research, request, and navigate NIH study section assignment to ensure your grant lands in front of reviewers who actually understand your science.

A complete guide to the NSF CAREER Award for the 2026 cycle: eligibility, funding, the integration requirement, reviewer expectations, and deadlines.

The largest AI nonprofit in America announced a billion-dollar grantmaking push. A deep look at the governance concerns, funding priorities, and what grant seekers should know.

A agency-by-agency breakdown of SBIR funding for clean energy startups, from DOE and DOD to EPA and USDA, with positioning strategies that match your technology to the right program.

SBIR data rights give small businesses up to 20 years of IP protection. Learn the DFARS and FAR rules, marking requirements, and negotiation strategies that keep your technology yours.

Serial SBIR winners build cross-agency portfolios by adapting core technology to DOD, NIH, and NSF missions. Here is how they do it under the 2026 rules.

Roughly 40% of SBIR Phase I awardees convert to Phase II. Agency data reveals what separates repeat winners from companies that never advance past feasibility.

Phase I findings often upend your original commercialization plan. How to reframe the pivot, rewrite your Phase II proposal, and keep agencies on your side.

TABA adds up to $50,000 on top of your SBIR/STTR award for IP, market research, and regulatory help. Here is how to claim it before the money disappears.

Faculty founders face unique SBIR hurdles around conflict of interest, IP assignment, and primary employment. Here is how to navigate the rules without derailing your startup or your tenure.

A data-driven comparison of SBIR grants and venture capital for startups, covering dilution, timelines, award sizes, and the scenarios where each funding path wins.

How to determine whether your grant collaboration requires a subaward or subcontract under 2 CFR 200, with budget, compliance, and indirect cost implications.

DARPA transferred its first autonomous-ready H-60Mx Black Hawk to the Army on March 20, capping a decade of ALIAS research. Now the same technology underpins an SBIR XL opportunity for small businesses building wildfire autonomy.

The Genesis Mission is the largest AI-for-science funding opportunity in DOE history, spanning 21 national challenges. A breakdown of eligibility, phasing, and competitive strategy.

EPA's own watchdog found $1.5 billion in Community Change Grants were properly awarded — no fraud, no waste, no issues. The Trump administration had already terminated all 80 of them. Here's what environmental justice organizations should do now.

FEMA awarded $875 million to secure FIFA World Cup 2026 host cities — but delayed funding, DHS shutdowns, and a 90-day countdown are creating unprecedented challenges for public safety agencies.

The NIH awarded 5,564 fewer grants in FY2025 than the year before, and FY2026 looks worse. A deep analysis of forward funding, politicization, leadership gaps, and what researchers should do now.

A coalition of 20 states and DC is challenging USDA grant conditions tied to DEI and immigration executive orders. The legal, financial, and strategic implications for grant recipients.

The DOJ spring 2026 Second Chance Act grant cycle is live after a turbulent year of cancellations and reauthorization. A full breakdown of eligibility, program categories, and competitive strategy.

After nearly a year of cancellation, lawsuits, and defiance of court orders, FEMA says it will restart the BRIC program. A full analysis of what happened, what it means for municipalities, and how to position for the next funding cycle.